Share Purchase Plan allotment
Capital Change Notice
Section 1: Issuer information
Name of issuer Infratil Limited
NZX ticker code IFT
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website)
NZIFTE0003S3
Currency NZD
Section 2: Capital change details
Number issued/acquired/redeemed 10,752,688
Nominal value (if any) Not applicable
Issue/acquisition/redemption price per security $4.65
Nature of the payment (for example, cash or other
consideration)
Cash
Amount paid up (if not in full) Fully paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
1
1.51%
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or the
Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
Allotment of 10,752,688
ordinary shares under a share
purchase plan conducted by
Infratil Limited
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
722,952,533
Treasury stock: 1,662,617
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
Not applicable
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Authorised by a resolution of
the Board. The share purchase
plan is made pursuant to NZX
Listing Rule 4.3.1(c) (as
modified by a class waiver
1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.
granted by NZX Regulation on
19 March 2020).
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The new shares will rank
equally with all other fully paid
ordinary shares on issue.
Date of issue/acquisition/redemption
2
2 July 2020
Section 3: Authority for this announcement and contact person
Name of person
authorised to make this announcement Phillippa Harford
Contact person for this announcement Mark Flesher
Contact phone number +64 4 473 2399
Contact email address Mark.flesher@hrlmorrison.com
Date of release through MAP
2 July 2020
2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: Issue of ordinary shares2020-07-01
“Capital Change Notice 2 July 2020 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in AFT Pharmaceuticals Limited. Section 1: Issuer information Name of issuer AFT Pharmaceuticals Limited NZX t…”
- IPL — Investore Property Limited: Allotment of Securities2020-05-19
“Capital Change Notice Section 1: Issuer information Name of issuer Investore Property Limited NZX ticker code IPL Class of financial product Ordinary shares in Investore Property Limited ISIN (If unknown, check on NZX website) NZIPLE0001S3 Currency NZD Section 2:…”
- AFT — AFT Pharmaceuticals Limited: Issue of ordinary shares2020-08-13
“Capital Change Notice AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com 13 August 2020 Issue of ordinary shares This notice is given un…”